Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: other routes
Type of information:
experimental study
Adequacy of study:
supporting study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Acceptable study report which meets basic scientific principles

Data source

Referenceopen allclose all

Reference Type:
other company data
Title:
Unnamed
Year:
1961
Report date:
1961
Reference Type:
secondary source
Title:
No information
Author:
BASF AG
Bibliographic source:
ECB IUCLID dataset
Reference Type:
secondary source
Title:
No information
Author:
BASF AG
Year:
2000
Bibliographic source:
OECD SIDS
Reference Type:
secondary source
Title:
1,6-Hexanediol
Author:
GDCh-Advisory Committee on Existing Chemicals of Environmental Relevance (BUA)
Year:
1992
Bibliographic source:
BUA Report 107 (October 1992)

Materials and methods

Principles of method if other than guideline:
Internal BASF method was used
GLP compliance:
no
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Hexane-1,6-diol
EC Number:
211-074-0
EC Name:
Hexane-1,6-diol
Cas Number:
629-11-8
Molecular formula:
C6H14O2
IUPAC Name:
hexane-1,6-diol

Test animals

Species:
mouse
Strain:
other: "Hannover"
Sex:
male/female

Administration / exposure

Route of administration:
intraperitoneal
Vehicle:
water
Details on exposure:
TEST MATERIAL
-Concentration: 10%, 20%
Doses:
800, 1600, 2000, 2500, 3200, 4600 mg/kg bw
No. of animals per sex per dose:
5 animals/dose
Control animals:
no
Details on study design:
- Duration of observation period following administration: 7 days
- Frequency of observations and weighing: daily observations
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, mortality

Results and discussion

Effect levels
Sex:
male/female
Dose descriptor:
LD50
Effect level:
ca. 2 300 mg/kg bw
Mortality:
800 mg/kg bw: 1/5 within 7 days (killed by cohoused animals)
1600 mg/kg bw: 0/5
2000 mg/kg bw: 0/5
2500 mg/kg bw. 3/5 within 24 h; 4/5 within 7 days
3200 mg/kg bw: 5/5 within 24 h
6400 mg/kg bw: 5/5 within 24 h
Clinical signs:
800 mg/kg bw: staggering and slight hyperactivity
1600 mg/kg bw: hyperactivity; lateral position, accelerated respiration, atonia, after 4 h without symptomps
2000 mg/kg bw: staggering, atonia, lateral position, intermittent respiration, narcotic state, after 3 days without symptoms
2500 mg/kg bw: hyperactivity, lateral positionor or back posture, atonia, intermittent respiration, 2 deaths within 4 h
3200 mg/kg bw: hyperactivity, lateral positionor or back posture, atonia, intermittent respiration,3 deaths within 5 h, white-colored eyes after exitus
6400 mg/kg bw: intermittent respiration, lateral position or back posture, atonia, narcotic state, deaths within 1 - 4 h; white-colored eyes after exitus
Gross pathology:
no abnormalities found

Applicant's summary and conclusion